Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature

BACKGROUND: Non-small cell lung cancer (NSCLC) represents more than about 80% of the lung cancer. The early stages of NSCLC can be treated with complete resection with a good prognosis. However, most cases are detected at late stage of the disease. The average survival rate of the patients with inva...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dan, Yang, William, Zhang, Yifan, Yang, Jack Y, Guan, Renchu, Xu, Dong, Yang, Mary Qu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245590/
https://www.ncbi.nlm.nih.gov/pubmed/30453959
http://dx.doi.org/10.1186/s12920-018-0413-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245590/
https://www.ncbi.nlm.nih.gov/pubmed/30453959
http://dx.doi.org/10.1186/s12920-018-0413-3

Ejemplares similares